Chronic coronary syndrome (stable angina)
Cardiology · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Stable, exertional, nitrate-relieved chest pain from fixed coronary disease. Confirm with functional/anatomical imaging, give secondary prevention (aspirin, statin) and antianginal therapy; revascularise for refractory symptoms or prognostic anatomy.
Red flags
- Refer to cardiology for diagnostic imaging and for angina not controlled on two antianginals, or high-risk features
- Admit/urgent assessment if angina becomes unstable (rest pain, crescendo, new severe onset)
- Urgent review for syncope or signs of severe aortic stenosis
Assessment
Investigations
- Resting ECG (often normal; may show prior MI/ischaemia)
- First-line imaging: CT coronary angiography for anatomy
- Functional testing (stress echo, perfusion MRI/SPECT) where appropriate
- Bloods: FBC, lipids, HbA1c, TFTs, U&E
- Echo for LV function/valves
- Invasive angiography +/- FFR if revascularisation considered
Management
- Lifestyle and risk-factor control
- Secondary prevention: antiplatelet (aspirin 75 mg; clopidogrel if intolerant) + high-intensity statin, plus ACEi if diabetes/HTN/HF
- Symptom relief: short-acting GTN for attacks; first-line antianginal beta-blocker OR rate-limiting CCB (diltiazem/verapamil); combine dihydropyridine CCB + beta-blocker if needed; add long- acting nitrate (isosorbide mononitrate), ivabradine, nicorandil or ranolazine as step-up
- Revascularisation (PCI or CABG) for symptoms refractory to medical therapy or prognostically important disease (e.g. left main, triple-vessel)
Disposition
Refer to cardiology for diagnostic imaging and for angina not controlled on two antianginals, or high-risk features.
Complications & pitfalls
- Progression to acute coronary syndrome/MI, heart failure from ischaemic cardiomyopathy, arrhythmia and sudden cardiac death, reduced exercise tolerance and quality of life
- Nitrate-related headache and tolerance; beta-blocker bradycardia
Exam pearls
- A change from a stable predictable pattern to rest pain or crescendo angina means the syndrome is no longer stable — treat as ACS. Beta-blockers plus rate-limiting (non-dihydropyridine) CCBs together risk profound bradycardia and heart block.
- Monitoring & follow-up: Review symptom control (CCS class), GTN use, adherence and side effects. Optimise lipids (LDL/non-HDL targets), BP, glycaemia, weight and smoking. Reassess if symptoms worsen or change pattern (?unstable). Ensure correct GTN technique; advise to call emergency services if pain unrelieved after repeated GTN.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.